Conflicting results from previous RCTs could be due to different doses of fish oil supplements, treatment duration, insufficient sample sizes, and use of hypoglycemic drugs or insulin therapy, which could mask the effects of fish oil supplementation in patients with hyperglycemia. The gene discussed is INS; the disease is Hyperglycemia.